...
首页> 外文期刊>Polymer international >Synthesis and in vitro biological evaluation as antitumour drug carriers of folate-targeted N-isopropylacrylamide-based nanohydrogels
【24h】

Synthesis and in vitro biological evaluation as antitumour drug carriers of folate-targeted N-isopropylacrylamide-based nanohydrogels

机译:叶酸靶向的N-异丙基丙烯酰胺基纳米水凝胶的合成及体外生物评价作为抗肿瘤药物载体

获取原文
获取原文并翻译 | 示例
           

摘要

Copolymeric nanohydrogels based on N-isopropylacrylamide, N-(pyridin-4-ylmethyl)acrylamide and tert-butyl-2-acrylamidoethyl carbamate, synthesized by microemulsion polymerization, were characterized using Fourier transform infrared spectroscopy and their size (38-52 nm) determined using quasielastic light scattering. Folic acid was covalently attached to the nanohydrogels (1.40 ± 0.07 mmol g~(-1)). Tamoxifen (6.7 ± 0.2-7.3 ± 1.2 μg TMX mg~(-1) nanohydrogel), a hydrophobic anticancer drug, and 5-fluorouracil (7.7 ± 0.7-10.14 ± 1.75 μg 5-FU mg~(-1) nanohydrogel), a hydrophilic anticancer drug, were loaded into the nanohydrogels. Maximum in vitro TMX release (77-84% of loaded drug) depended on interactions of the drug with hydrophobic clusters of the nanogels; however, no nanogel/5-FU interactions allowed total release of the loaded drug. The cytotoxicity of unloaded nanohydrogels in MCF7, T47D and HeLa cells was low. Cell uptake of nanogels without bound folic acid took place in the three cell types by unspecific internalization in a time-dependent process. Cell uptake increased for folic acid-targeted nanohydrogels in T47D and HeLa cells, which have folate receptors. The administration of 10 and 30 μmol L~(-1) TMX by TMX-loaded nanogels and 10 μmol L~(-1) 5-FU by 5-FU-loaded nanogels was effective on the three cell types, and the best results were obtained for folic acid-targeted nanohydrogels.
机译:通过微乳液聚合合成了基于N-异丙基丙烯酰胺,N-(吡啶-4-基甲基)丙烯酰胺和叔丁基-2-丙烯酰胺基氨基甲酸乙酯的共聚纳米水凝胶,并使用傅里叶变换红外光谱进行了表征,并确定了它们的尺寸(38-52 nm)使用准弹性光散射。叶酸共价附着在纳米水凝胶上(1.40±0.07 mmol g〜(-1))。他莫昔芬(6.7±0.2-7.3±1.2μgTMX mg〜(-1)纳米水凝胶),疏水性抗癌药和5-氟尿嘧啶(7.7±0.7-10.14±1.75μg5-FU mg〜(-1)纳米水凝胶),将亲水性抗癌药物加载到纳米水凝胶中。体外TMX的最大释放量(占载药量的77-84%)取决于药物与纳米凝胶的疏水簇的相互作用。但是,没有nanogel / 5-FU相互作用允许完全释放负载的药物。未装载的纳米水凝胶在MCF7,T47D和HeLa细胞中的细胞毒性较低。在不依赖叶酸的情况下,三种类型的细胞通过非特异性内化作用在时间依赖性过程中吸收了纳米凝胶。在叶酸受体的T47D和HeLa细胞中,针对叶酸的纳米水凝胶的细胞摄取增加。载有TMX的纳米凝胶分别施用10和30μmolL〜(-1)TMX和载有5 FU的纳米凝胶施用10μmolL〜(-1)5-FU对这三种细胞类型均有效,且效果最佳获得了针对叶酸的纳米水凝胶。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号